Bank of America downgraded Vitamin Shoppe VSI from Buy to Neutral and lowered the price objective from $68.00 to $55.00.
Bank of America commented, "We are downgrading VSI to Neutral from Buy on a deceleration in trends and what we believe is a heightened competitive environment. VSI reported 4Q12 operating EPS of $0.36 vs. operating EPS of $0.38 LY and our $0.43 estimate. Reported EPS of $0.32 includes Canada startup and Super Supplements acquisition costs. Management noted that Hurricane Sandy impacted EPS by $0.04. The comp came in at 5.2%, including a 1.6% impact from Sandy, a deceleration from an adjusted 8.6% in Q3. We attribute the comp slowdown to increased competitive activity and a strong comparison in weight management."
Vitamin Shoppe closed at $51.98 on Wednesday.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in